biotech
Designer Diagnostics Sponsors StopNTMnow.com
Filed in archive Diagnostics, Methodologies and Instrumentation by ruth on May 9, 2006
Designer Diagnostics Sponsors StopNTMnow.com
Designer Diagnostics, a subsidiary of biotech firm Nutra Pharma, sponsored the website, StopNTMnow.com, an informative portal and forum about NonTuberculosis Mycobacterium.
"It is important to educate the public about the importance of NTMs, as they are a leading cause of death in HIV/AIDS and immuno-suppressed patients," explained Rik J. Deitsch, Chairman and CEO of Nutra Pharma Corporation. "There are currently over 40 million people suffering from HIV/AIDS that could benefit from this information. For example, most people don't realize that NTMs can be traced to everyday events such as sitting in hot tubs at the community gym."


Organizers are hoping that, thru this educational campaign, patients will be informed about early detection and late-stage NTM infections may be prevented. In March, Designer Diagnostic launched a diagnostic test kit for the rapid isolation and identification of NTM. For more information on Nontuberculosis Mycobacterium, check out the StopNTMNow.


Permalink: Designer Diagnostics Sponsors StopNTMnow.com
Tags: diagnostics  tuberculosis  biotech  designer  stopntmnow  designer+diagnostics  diagnostics+sponsors  spons 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/21611
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Designer Diagnostics Sponsors StopNTMnow.com:

  • Currently 8.67/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 8.67 out of 3 vote(s) cast.
Subscribe
Share It
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!